Akeso Biopharma
About:
Akeso Biopharma is a biopharmaceutical company committed to the discovery, development, and commercialization of therapies.
Website: http://www.akesobio.com
Top Investors: OrbiMed, Shenzhen Capital Group, Ally Bridge Group, Qianhai Fund of Funds, Loyal Valley Capital
Description:
The company has built a global level of bio-pharmaceutical research and development and industrialization platform; established for cancer, autoimmune diseases, inflammation and cardiovascular disease of the rich product line. The scale of the company's platform, hardware and software facilities, the number of new drug product lines, R & D team in the country are the same industry-leading level. Kang Fang biological has been with the international and domestic listed pharmaceutical companies to establish a cooperative relationship, the joint development of innovative antibodies to new drugs, is a strategic cooperation in the form of development of new drugs in the forerunner.
$470M
$1B to $10B
Zhongshan, Anhui, China
2012-01-01
bd(AT)akesobio.com
Li Baiyong, Wang Zhongmin, Xia Yu
501-1000
2024-10-13
Public
© 2025 bioDAO.ai